Thank you for choosing to subscribe to the eTOC for Clinical Drug Investigation

Enter your Email address:

Adis may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy.

Clinical Drug Investigation

Adis Online Logo

Login
Register
Activate Subscription
eTOC
Help

Advanced Search
Saved Searches
Recent Searches

You currently have no recent searches

Home	AdisOnline Home	Current Issue	Previous Issues	Published Ahead-of-Print	Collections	Services	Information

Article Collections

For Librarians

RSS Feeds

Rights & Permissions

Reprints & ePrints

Supplements

Current Issue: September 1, 2010 - Volume 30 - Issue 9

Subscribe to eTOC

Add Item(s) to:

An Existing Folder

A New Folder

Folder Name:

Description:

The item(s) has been successfully added to "".

Email to a Colleague

Colleague's E-mail is Invalid

Your Name: (optional)

Your Email:

Colleague's Email:

Separate multiple e-mails with a (;).

Message:
Thought you might appreciate this item(s) I saw in Clinical Drug Investigation.

Send a copy to your email

Your message has been successfully sent to your colleague.

Some error has occurred while processing your request. Please try after some time.

Export to.

End Note
Procite
Reference Manager

Save my selection

Featured Articles

Subscribe To This RSS FeedSubscribe To This RSS Feed

Select All | Hide Details

Free Access
Purchase Access
Partial Access

Fixed or Adjustable Maintenance-Dose Budesonide/Formoterol Compared with Fixed Maintenance-Dose Salmeterol/Fluticasone Propionate in Asthma Patients Aged >=16 Years: Post Hoc Analysis of a Randomized, Double-Blind/Open-Label Extension, Parallel-Group Study

Aalbers, René

Clinical Drug Investigation. 30(7):439-451, July 1, 2010.

doi: 10.2165/11533420-000000000-00000

Purchase Access

+ Favorites

EPUB EPUB

PDF (622 KB)

Abstract

Abstract:

Effects of AZD0837, a Novel Direct Thrombin Inhibitor, on the Electrophysiological Properties of the Human Heart: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study

Walfridsson, Håkan; Johansson, Birgitta; Englund, Anders; Kennebäck, Göran; Schwieler, Jonas; Kongstad, Ole; Wåhlander, Karin; Malm?, Anders R.; Edvardsson, Nils

Clinical Drug Investigation. 30(7):461-471, July 1, 2010.

doi: 10.2165/11536300-000000000-00000

Purchase Access

+ Favorites

EPUB EPUB

PDF (439 KB)

Abstract

Abstract:

Safety and Tolerability of a New Formulation of Pancrelipase Delayed-Release Capsules (CREON(R)) in Children Under Seven Years of Age with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis: An Open-Label, Multicentre, Single-Treatment-Arm Study

Graff, Gavin R.; McNamara, John; Royall, James; Caras, Steven; Forssmann, Kristin

Clinical Drug Investigation. 30(6):351-364, June 1, 2010.

doi: 10.2165/11533390-000000000-00000

Purchase Access

+ Favorites

EPUB EPUB

PDF (382 KB)

Abstract

Abstract:

Efficacy and Safety of the Combined Oral Contraceptive Ethinylestradiol/Drospirenone (Yasmin(R)) in Healthy Chinese Women: A Randomized, Open-Label, Controlled, Multicentre Trial

Guang-Sheng, Fan; Mei-Lu, Bian; Li-Nan, Cheng; Xiao-Ming, Cao; Zi-Rong, Huang; Zi-Yan, Han; Xiao-Ping, Jing; Jian, Li; Shu-Ying, Wu; Cheng-Liang, Xiong; Zheng-Ai, Xiong; Tian-Fu, Yue

Clinical Drug Investigation. 30(6):387-396, June 1, 2010.

doi: 10.2165/11318460-000000000-00000

Purchase Access

+ Favorites

EPUB EPUB

PDF (433 KB)

Abstract

Abstract:

Select All

Username or Email:

Password:

Remember me

Forgot Password?

Need to Activate a New Subscription?
Recently purchased a subscription? Login or Register a new account and enter your subscription ID, or Subscribe Now!

Forgot your Password?

Enter and submit the email address you registered with. An email with instructions to reset your password will be sent to that address.

Email:

Forgot your Password?

Link to reset your password has been sent to specified email address.

Remember me

What does "Remember me" mean?
By checking this box, you'll stay logged in for 14 days or until you logout. You'll get easier access to your articles, collections, media, and all your other content, even if you close your browser or shut down your computer.

To protect your most sensitive data and activities (like changing your password), we'll ask you to re-enter your password when you access these services.

What if I'm on a computer that I share with others?
If you're using a public computer or you share this computer with others, we recommend that you uncheck the "Remember me" box.

Announcement

2009 Impact Factors just released!

Clinical Drug Investigation has a new Impact Factor of 1.414

an 8.7% increase over prior year